国立癌症研究所癌症中心指定和住院免疫功能低下癌症患者的 30 天死亡率。
National Cancer Institute Cancer Center designation and 30-day mortality for hospitalized, immunocompromised cancer patients.
机构信息
University of Michigan School of Nursing, Ann Arbor, USA.
出版信息
Cancer Invest. 2010 Aug;28(7):751-7. doi: 10.3109/07357901003735667.
PURPOSE
To examine 30-day mortality and National Cancer Institute (NCI) designation for cancer patients who are immunocompromised and hospitalized.
METHOD
Secondary analysis of 1998 and 1999 hospital claims, cancer registry, and vital statistics (n = 10,370) linked to survey and administrative data from 160 Pennsylvania hospitals. Logistic regression models estimated the effects of NCI designation on the likelihood of 30-day mortality.
RESULTS
NCI-designated centers were associated with a 33% reduction in the likelihood of death, after adjusting for patient, hospital, and nursing characteristics.
CONCLUSIONS
Immunocompromised cancer patients have lower mortality in NCI-designated hospitals. Identification and adoption of care processes from these institutions may improve mortality.
目的
调查免疫功能低下并住院的癌症患者的 30 天死亡率和美国国家癌症研究所（NCI）指定。
方法
对 1998 年和 1999 年的医院索赔、癌症登记和生命统计数据（n=10370）进行二次分析，并与来自宾夕法尼亚州 160 家医院的调查和行政数据相关联。逻辑回归模型估计了 NCI 指定对 30 天死亡率的可能性的影响。
结果
在调整了患者、医院和护理特征后，NCI 指定的中心与死亡可能性降低 33%相关。
结论
免疫功能低下的癌症患者在 NCI 指定的医院中的死亡率较低。识别和采用这些机构的护理流程可能会提高死亡率。
Zotero 插件